Description: 

Date/Time: April 10, 2024 | 10:00 - 10:25 am ET

Note: This session will be broadcast as a live Zoom webinar, along with the keynote. Please stay on the live Zoom after opening remarks for the keynote session.

This year’s Sepsis Alliance AMR Conference will open with a patient story from Ella Balasa. Ella is a passionate patient advocate, AMR survivor, and lives with cystic fibrosis. She has experienced numerous hospitalizations and healthcare encounters throughout her life. During these opening remarks, learners will hear Ella’s journey battling antibiotic-resistant infections firsthand and be empowered to better advocate for and amplify the patient’s voice in their own practice. 

Learning Objectives:

At the end of this session, the learner should be able to:

• List key factors in advocating for and raising the patient’s voice

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Ella Balasa, Patient Advocate and AMR Survivor

Steven Q. Simpson, MD, Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine

Description: 

Date/Time: April 10, 2024 | 10:30 - 11:05 am ET

According to Centers for Disease Control and Prevention (CDC), more than half of all human infections can be spread by animals. One Health has become an increasingly important approach for addressing several issues including endemic zoonotic diseases, environmental contamination, climate change, food safety, and the global threat of Antimicrobial Resistance (AMR) collaboratively across sectors and disciplines.

During this timely keynote presentation, subject matter experts from both the animal and human health fields of medicine will share unique perspectives and experiences about the growing threat of AMR and explore how the One Health approach can, and is, providing a framework to control public health threats. How diseases are spread amongst plants, animals, humans, and the environment will also be discussed.

Learning Objectives:

At the end of this session, the learner should be able to:

• Compare the One Health AMR approach perspectives and experiences through the differing lenses of animal and human health;
• Recognize the importance of the One Health approach in reducing antimicrobial resistant infections and in improving human and animal health.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM, Executive Director

Jason G. Newland, MD, MEd, Pediatric Infectious Diseases

Description: 

Date/Time: April 10, 2024 | 11:10 - 11:45 am ET

One Health represents a global initiative aimed at fostering cross-disciplinary partnerships and communication across all areas of healthcare, encompassing humans, animals, and the environment. This collaborative approach seeks to propel biomedical breakthroughs, improve the effectiveness of public health measures, and elevate our medical education and clinical practices. In this session, the intersection of human, animal, and environmental health will be explored and its effectiveness through the Minnesota One Health Antibiotic Stewardship Collaborative. Defining One Health and explaining why antibiotic resistance transcends disciplinary boundaries, impacting not only human health but also that of animals and ecosystems. The principles and strategies of antibiotic stewardship through a One Health lens, highlighting the interconnectedness of health across various sectors will be explored, as well as the pivotal roles and responsibilities of multidisciplinary teams involved in antibiotic stewardship across diverse settings.

Learning Objectives:

At the end of this session, the learner should be able to:

• Define One Health and describe why antibiotic resistance is a One Health issue;
• Describe antibiotic stewardship principles and implementation strategies through a One Health perspective;
• Identify the roles and responsibilities of the multidisciplinary team involved in antibiotic stewardship within multiple settings.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Kristen Clark, DVM, MPH, DACVPM, CCRT, Director, Minnesota One Health Antibiotic Stewardship Collaborative

Description: 

Date/Time: April 10, 2024 | 11:50 am - 12:20 pm ET

Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis will be an exploration into the forefront of medical innovation. In this sponsored session, Recce Pharmaceuticals unveils their portfolio approach to tackling the growing threats of antimicrobial resistance (AMR) and sepsis, two critical challenges in modern healthcare. Through innovative synthetic anti-infectives, Recce's breakthrough clinical-stage technology aims to go beyond conventional antibiotics, offering a novel, broad-spectrum solution to combatting resistant strains of bacteria and addressing the urgent need for effective sepsis treatments.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

James Graham, Managing Director & Chief Executive Officer

Description: 

Date/Time: April 10, 2024 | 12:20 - 12:30 ET

Description: 

Date/Time: April 10, 2024 | 12:30 - 1:00 pm ET

In this insightful session, the presenters will provide attendees with a formal examination of the pressing issue of superbugs, framed within a deeply personal narrative. The intricate world of infectious diseases, focusing on the notorious ESKAPE pathogens and their alarming implications will be explored, in addition to the nuances of Acinetobacter baummanii, a highly virulent bacterial pathogen.

The foundational principles of phage therapy, a promising frontier in the battle against sepsis caused by antibiotic-resistant bacteria, will be discussed, empowering participants to grasp the intricacies of superbugs and their potential therapeutic interventions.

Learning Objectives:

At the end of this session, the learner should be able to:

• Describe the ESKAPE pathogens;
• Identify why Acinetobacter baumannii is a particularly virulent bacterial pathogen;
• List the basic principles behind phage therapy for combatting sepsis.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Steffanie Strathdee, PhD, Associate Dean of Global Health Sciences

Thomas Patterson, PhD, Professor of Psychiatry

Description: 

Date/Time: April 10, 2024 | 1:05 - 1:45 ET

In this session, vital strategies to optimize antibiotic use post-hospitalization will be explored. Antibiotic stewardship is imperative in healthcare, and this session will provide critical principles guiding this practice. The complexities surrounding antibiotic overuse at discharge will be discussed, providing a comprehensive summary of existing knowledge in this area. Understanding these nuances is crucial in identifying opportunities for improvement and implementing effective discharge antibiotic stewardship interventions.

By the end of this presentation, attendees will gain a deeper understanding of antibiotic stewardship principles, be equipped to summarize the landscape of antibiotic overuse at discharge, and have the ability to identify key strategies for enhancing antibiotic use post-hospitalization.

Learning Objectives:

At the end of this session, the learner should be able to:

• Review principles of antibiotic stewardship;
• Summarize what is known about antibiotic overuse at discharge;
• Identify opportunities to improve antibiotic use at discharge and key discharge antibiotic stewardship interventions.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Emily Sydnor Spivak, MD, MHS, FIDSA, FSHEA, Associate Professor of Medicine, Division of Infectious Diseases

Description: 

Date/Time: April 10, 2024 | 1:45 - 2:15 pm ET

This sponsored session explores the definition of sepsis, global statistics, and the use of sepsis bundles in care. The critical overlap between sepsis and antimicrobial resistance (AMR) will be highlighted, along with the vital role of diagnostics in guiding treatment decisions and combating AMR.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Amanda L. Suchanek, Ph.D., Medical Advisor, US Medical Affairs

Description: 

Date/Time: April 10, 2024 | 2:15 - 2:25 pm ET

Description: 

Date/Time: April 10, 2024 | 2:25 - 3:00 pm ET

While antibiotic resistant bacteria have existed for millions of years and pose an increasing global health threat to all populations, it’s only recently that there has been increased recognition of drug-resistant infection trends in infants and children. During this session, the presenter will give an overview of the current landscape of AMR infections in pediatric populations, cover the common multidrug-resistant organisms (MDROs) leading to infections, and discuss how to manage them.  

Learning Objectives: 

At the end of this session, the learner should be able to:

• Describe the landscape of antimicrobial-resistant infections in the pediatric population; 
  
• Review common antimicrobial-resistant organisms leading to infections in the pediatric population; 
• Explain the management of antimicrobial-resistant infections in the pediatric population. 

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Rachel Medernach, MD, MSCI, Assistant Professor

Description: 

Date/Time: April 10, 2024 | 3:05 - 3:45 pm ET

CDC’s Core Elements of Hospital Antibiotic Stewardship (AS) offer providers and facilities a set of key principles to guide efforts to improve antibiotic use and, therefore, advance patient safety and improve outcomes. These have catalyzed the development of AS programs and driven national improvements in antibiotic prescribing and outcomes. Inspired by this success, CDC recently released the Hospital Sepsis Program Core Elements to optimize patient care and help clinicians, hospitals, and health systems in efforts to improve management and outcomes of sepsis. These core elements outline structural and procedural components that are associated with the multidisciplinary expertise required to support the care of patients with sepsis. In this session, attendees will learn about the hospital AS and sepsis program core elements; explore the nurse’s role, responsibility, and scope of practice in AS and sepsis management; and identify nursing strategies to optimize antibiotic use. 

Learning Objectives:

At the end of this session, the learner should be able to:

• Describe CDC Core Elements of Hospital Antibiotic Stewardship Programs and CDC Hospital Sepsis Program Core Elements;
• Identify nurse’s role, responsibility and scope of practice in hospital antibiotic stewardship and sepsis management;
• Identify strategies for nurses to engage in optimization of hospital antibiotic use. 

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Mary Lou Manning, PhD, CRNP, CIC, FAPIC, FSHEA, FAAN, Professor

Description: 

Date/Time: April 10, 2024 | 3:45- 4:25 pm ET

Inappropriate antibiotic prescribing commonly occurs in the outpatient setting. Antimicrobial stewardship programs are recommended for use in the hospital, but less is known about whether and how they will work in the ambulatory setting. Pressure for antibiotics is perceived as a major barrier to the more judicious use of antibiotics. To improve the effectiveness and sustainability of outpatient antimicrobial stewardship, it is critical to engage clinicians in recognizing that their behavior contributes to antibiotic overuse and address the pressure to prescribe antibiotics. This session aims to provide learners with a comprehensive understanding of their role in preventing antimicrobial resistance, acquiring practical knowledge on how individual actions contribute to this global challenge.

Learning Objectives:

At the end of this session, the learner should be able to:

• Restate the importance of antimicrobial stewardship both in the hospital and community setting;
• Describe how they can help prevent antimicrobial resistance.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Alyssa R. Letourneau, MD, MPH, FIDSA, Assistant Professor of Medicine

Description: 

Date/Time: April 10, 2024 | 4:25 - 4:30 pm ET

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Description: 

Date/Time: April 11, 2024 | 10:00 - 10:20 am ET

The second day of the Sepsis Alliance AMR Conference will open with a patient story from Rosie Bartel. Rosie is a passionate patient advocate and has experienced sepsis and septic shock more than fourteen times. Rosie has faced numerous hospitalizations and healthcare encounters following a MRSA infection that developed following a total right knee replacement in 2009. During these opening remarks, Rosie will share her journey battling antibiotic-resistant infections firsthand, empowering learners to better advocate for and amplify the patient’s voice in their own practice. 

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Rosie Bartel, Patient Advocate and Sepsis Survivor

Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA, Infection Control Officer and Medical Director of Research

Description: 

Date/Time: April 11, 2024 | 10:25 - 11:05 am ET

In the wake of the COVID-19 pandemic, the healthcare landscape has been dramatically altered, revealing interconnected challenges that demand urgent attention. In this keynote session, the complex interplay between Antimicrobial Resistance (AMR), sepsis, pandemics, and climate change will be highlighted alongside their profound implications for global health. The evolving clinical manifestations of COVID-19 associated viral sepsis will be explored, providing a comprehensive understanding of the current clinical landscape.

This keynote session will also shed light on the often-overlooked healthcare disparities magnified by the COVID-19 crisis, particularly concerning AMR and COVID-19 related outcomes. The differential impacts of COVID-19 on various communities will be discussed, emphasizing the urgent need for targeted interventions to mitigate disparities and improve health equity. By fostering a deeper understanding of these interconnected issues, we can work towards innovative solutions that safeguard public health and promote resilience in the face of emerging global health threats.

Learning Objectives:

At the end of this session, the learner should be able to:

• Describe the current clinical picture of COVID-19 associated viral sepsis;
• Identify the interconnection between AMR, sepsis, pandemics, and climate change;
• Examine AMR and COVID-19 related healthcare disparities, and the impact of COVID-19 on various communities.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Uzma Syed, DO, Infection Disease Specialist

Description: 

Date/Time: April 11, 2024 | 11:05 - 11:25 am ET

Among the limited studies available, it has been found that individuals from Black, Hispanic, and economically disadvantaged backgrounds face an elevated susceptibility to contracting community-acquired antibiotic-resistant organisms like methicillin-resistant Staphylococcus aureus and drug-resistant Streptococcus pneumoniae. This presentation sheds light on the critical issue of racial disparities within antimicrobial-resistant infections, focusing on Staphylococcus aureus bloodstream infections (SAB) and infections caused by Carbapenem-resistant (CR) organisms.

By identifying risk factors and variances in clinical characteristics and outcomes, attendees will gain insight into the nuanced challenges faced by different racial groups in combating antimicrobial-resistant infections. Actionable recommendations aimed at mitigating these inequities and fostering more equitable healthcare outcomes among patients with antimicrobial-resistant infections will be discussed, promoting a deeper understanding of this pressing issue and exploring strategies for driving positive change in patient care.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Learning Objectives:

At the end of this session, the learner should be able to: 

• Evaluate potential differences in clinical characteristics, microbiology, and outcomes among Black and white patients diagnosed with Staphylococcus aureus bloodstream infections (SAB);
• Identify risk factors or differences in clinical characteristics and outcomes among Black and white patients with infections caused by Carbapenem-resistant (CR) organisms;
• Identify recommendations to mitigate inequities among patients with Antimicrobial-Resistant Infections.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Felicia Ruffin, PhD, MSN, BSN, BA, Clinical Research Program Leader

Description: 

Date/Time: April 11, 2024 | 11:30 am - 12:00 pm ET

Note: This session will not be available for review after the conference. Slides will not be available.

Enhancing sepsis patient outcomes in the context of increasing antimicrobial resistance requires continuous quality and performance improvement initiatives across the hospital. This sponsored session will focus on those improvements from the perspective of the clinical microbiology laboratory. Despite best efforts, hospitals are still having blood culture collection issues, including specimen contamination, low blood fill volume, and an inappropriate number of blood culture sets collected, which results in costly redraws, lab re-work, and delays in patient care. An efficient bloodstream infection diagnostic pathway begins with high-quality blood culture samples and ends with accurate pathogen identification and antimicrobial susceptibility testing, which informs patient care. Antimicrobial stewardship programs, combined with rapid diagnostics, are critical to optimize the use of antibiotics, effectively treat infections, protect patients from harms caused by unnecessary antibiotic use, reduce the risk of developing antibiotic resistance, and reduce hospital costs and length of stay.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Masashi Waga, Technical Director, Clinical Microbiology and Senior Manager, Clinical Microbiology

Description: 

Date/Time: April 11, 2024 | 12:00 - 12:15 ET

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Description: 

Date/Time: April 11, 2024 | 12:15 - 12:45 pm ET

Antibiotics have been critical for treating the infectious complications that can occur in individuals who are being treated for malignancy. These lifesaving medications are becoming less effective as rates of resistance increase. This session will describe the state of emerging resistance seen in cancer patients and discuss potential future approaches to help reduce resistance in this vulnerable population.

Learning Objectives:

At the end of this session, the learner will be able to:

• Describe the epidemiology of antibiotic resistance in patients with cancer;
• Discuss newer antimicrobial strategies that could be used to treat drug-resistant infections in these patients.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

David Greenberg, MD, Professor of Infectious Diseases and Microbiology

Description: 

Date/Time: April 11, 2024 | 12:50 - 1:10 pm ET

The U.S. federal government has been addressing resistant infections for decades. In 2014, President Barak Obama signed an executive order that brought all federal efforts to combat antibiotic resistance together. The Executive Order 13676 established the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), and formally established the Federal Interagency CARB Task Force to coordinate all federal efforts. PACCARB offers guidance to the U.S. Secretary of Health and Human Services on addressing antimicrobial resistance (AMR) and operates within the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. PACCARB, comprised of experts from various fields, evaluates government efforts in human, animal, and environmental health.  

This session will briefly summarize and review the PACCARB charter and a few of the current PACCARB reports and recommendations.

Learning Objectives: 

At the end of this session, the learner should be able to: (AVOID USING DISCUSS and UNDERSTAND)

• Describe the purpose, objectives, and scope of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB);
• List PACCARB reports and describe key PACCARB recommendations.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Jason G. Newland, MD, MEd, Pediatric Infectious Diseases

Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM, Executive Director

Description: 

Date/Time: April 11, 2024 |1:15 - 1:30 pm ET

In November 2023, Sepsis Alliance released a new survey report to mark World Antimicrobial Awareness Week. The new research in this report found that healthcare C-suite executives believe the threat of antimicrobial resistance (AMR) is only growing worse and healthcare professionals are responsible for helping to solve the AMR problem. Alex from Sepsis Alliance will present the results and share key takeaways from this groundbreaking survey.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Alex Sadorf Colvin, Director, Marketing and Communications

Description: 

Date/Time: April 11, 2024 | 1:35 - 1:45 pm ET

As a freshman at Brown University, Tori Kinamon had to wish her teammates luck as they traveled to a gymnastics meet and she stayed on campus battling unexplained pain and swelling. She would soon learn that she was dealing with a severe methicillin-resistant Staphylococcus aureus (MRSA) infection and it was progressing into sepsis. Tori shares her story and learnings.   

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Tori Kinamon, MD Candidate

Description: 

Date/Time: April 11, 2024 | 1:50 - 2:10 pm ET

Description: 

Date/Time: April 11, 2024 | 2:10 - 2:35 pm ET

Due to a variety of factors such as age, multiple co-morbidities, medical devices, and wounds, the over 1 million residents living in the nation’s long-term care facility are at high risk for healthcare-associated infections. Some pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), can live on a person’s skin and in their nose without them knowing and without making them sick. Proactively taking steps to decolonize can reduce the risks and spread of infections and AMR. This session will evaluate the evidence and rationale for decolonization in both hospitals and nursing homes, and will also review available resources and discuss the importance of education and training.

Learning Objectives

At the end of this session, the learner should be able to:

• Discuss the evidence and rationale for decolonization as a strategy to reduce healthcare-associated infections and antibiotic resistant pathogens in hospitals;
• Summarize the latest evidence for decolonization to reduce infections and antibiotic resistant pathogens in nursing homes;
• Describe the importance of training and the types of resources available for educational materials for decolonization.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Susan Huang, MD MPH, Chancellor’s Professor

Description: 

Date/Time: April 11, 2024 | 2:40 - 3:15 pm ET

Candida auris has swiftly emerged as a global health concern, presenting unique challenges in healthcare settings worldwide. This session delves into the intricate landscape of this multidrug-resistant fungal pathogen, highlighting its epidemiology, clinical implications, and management strategies. From infection control measures to treatment modalities, the complexities associated with managing this emerging fungal pathogen in diverse healthcare settings will be explored. Attendees will gain insights into the molecular mechanisms underpinning its ability to evade host defenses and establish persistent infections, enhancing understanding of its clinical impact.

Learning Objectives:

At the end of the session, the learner should be able to:

• Identify the challenges associated with caring for patients colonized by Candida auris as an emerging fungal pathogen;
• List the virulence factors of Candida auris.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Mahmoud A. Ghannoum, PhD, MBA, FIDSA, FAAM, Professor

Description: 

Date/Time: April 11, 2024 | 3:20- 3:40 pm ET

Outpatient antibiotic stewardship is imperative in safeguarding both individual patient well-being and public health. In this session the detrimental repercussions of inappropriate outpatient antibiotic prescribing will be explored, unraveling its cascading effects on antibiotic resistance and healthcare outcomes. The key approaches essential for effective outpatient antibiotic stewardship will be presented, equipping attendees with the knowledge to navigate this complex landscape. Additionally, the pivotal roles various healthcare stakeholders play in driving the expansion of outpatient antibiotic stewardship efforts, emphasizing the collaborative nature required for meaningful progress in this vital area of healthcare, will be discussed.

Learning Objectives:

At the end of this session, the learner should be able to:

• Describe the impact of inappropriate outpatient antibiotic prescribing on individual patients and public health;
• List key approaches for outpatient antibiotic stewardship;
• Identify the roles of different healthcare stakeholders in supporting the expansion of outpatient antibiotic stewardship efforts.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Rachel Zetts, MPH, Senior Officer, Antibiotic Resistance Project

Description: 

Date/Time: April 11, 2024 | 3:40 - 4:00 ET

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Thomas Heymann, President & CEO